Publication | Closed Access

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 6. A comparison of pindolol and propranolol in treatment of patients with angina pectoris. The role of intrinsic sympathomimetic activity

Adrenal GlandCardiovascular DiseaseMedicineAntihypertensive TherapyPhysiologyCardiovascular PharmacologyAngina PectorisClinical PharmacologyPharmacotherapyBeta-adrenergic PharmacologyPart 6PharmacologyCardiology